Literature DB >> 10943982

Preoperative embolization of hypervascular skull base tumors.

A Gruber1, G Bavinzski, M Killer, B Richling.   

Abstract

The purpose of the present study is to review the results and complications of preoperative embolization of hypervascular skull base tumors at a neurosurgical center with a team of neurosurgeons cross-experienced in the application of both microsurgery and endovascular techniques. One hundred and twenty-eight endovascular approaches were performed in 66 patients treated for skull base meningiomas (n = 41), paragangliomas of the temporal bone (n = 18), and juvenile nasopharyngeal angiofibromas (n = 7). One death and 2 permanent disabilities were attributable to endovascular therapy. These complications occurred early in our experience (1982-1989) and were related to thromboembolic events rather than complications of transcatheter embolization itself. Our current standard is to perform transfemoral superselective embolizations with either finely corpuscular embolizing substances (PVA particles) or cyanoacrylates (NBCA) under local anesthesia. Using this protocol no embolization-related complications have occurred over the last 9 years. We thus conclude that preoperative embolization of hypervascular skull base tumors can be accomplished safely with the endovascular techniques now available.

Entities:  

Mesh:

Year:  2000        PMID: 10943982     DOI: 10.1055/s-2000-8321

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  14 in total

1.  Preoperative devascularization of a circumferential osteogenic metastasis to the upper cervical spine by direct percutaneous needle puncture: a technical note.

Authors:  T Liebig; H Henkes; M Kirsch; M Piotin; P Jans; D Kühne
Journal:  Neuroradiology       Date:  2005-07-02       Impact factor: 2.804

Review 2.  Interventional neuroradiology of the head and neck.

Authors:  D Gandhi; J J Gemmete; S A Ansari; S K Gujar; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2008-09-10       Impact factor: 3.825

3.  Embolization in the head and neck.

Authors:  Daniel Cooke; Basavaraj Ghodke; Sabareesh Kumar Natarajan; Danial Hallam
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

Review 4.  Off-label use of drugs and devices in the neuroendovascular suite.

Authors:  M M Abdihalim; A E Hassan; A I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2013-03-21       Impact factor: 3.825

5.  [Intratumoral Onyx embolisation in the management of juvenile nasopharyngeal angiofibroma].

Authors:  M Lehmann; S Ulrich; U Reineke; U Hamberger; U Dietrich; H Sudhoff
Journal:  HNO       Date:  2010-08       Impact factor: 1.284

Review 6.  Surgery of the ear and the lateral skull base: pitfalls and complications.

Authors:  Bernhard Schick; Julia Dlugaiczyk
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

7.  Intratumoral injection of cyanoacrylate glue in head and neck paragangliomas.

Authors:  Daniel Giansante Abud; Charbel Mounayer; Goetz Benndorf; Michel Piotin; Laurent Spelle; Jacques Moret
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

Review 8.  Necrosis score, surgical time, and transfused blood volume in patients treated with preoperative embolization of intracranial meningiomas. Analysis of a single-centre experience and a review of literature.

Authors:  A Nania; F Granata; S Vinci; A Pitrone; V Barresi; R Morabito; N Settineri; F Tomasello; C Alafaci; M Longo
Journal:  Clin Neuroradiol       Date:  2013-03-24       Impact factor: 3.649

Review 9.  Interventional Management of Head and Neck Tumors.

Authors:  Mudassar Kamran; Adam N Wallace; Amole Adewumi
Journal:  Semin Intervent Radiol       Date:  2020-05-14       Impact factor: 1.513

10.  First clinical experience in applying XperGuide in embolization of jugular paragangliomas by direct intratumoral puncture.

Authors:  Laurent Spelle; Daniel Ruijters; Drazenko Babic; Robert Homan; Peter Mielekamp; Jeremy Guillermic; Jacques Moret
Journal:  Int J Comput Assist Radiol Surg       Date:  2009-06-13       Impact factor: 2.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.